IDegAsp produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes

被引：0
|
作者：
Nosek, L. [1 ]
Heise, T. [1 ]
Klein, O. [1 ]
Coester, H. -V. [1 ]
Roepstorff, C. [2 ]
Svendsen, A. [2 ]
Haahr, H. [2 ]
机构：
[1] Profil Inst Stoffwechselforsch, Neuss, Germany
[2] Novo Nordisk AS, Soborg, Denmark
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1041
引用
收藏
页码：S418 / S419
页数：2
相关论文
共 50 条
  • [21] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    [J]. LANCET, 2014, 384 (9948): : 1095 - 1095
  • [22] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes RESPONSE
    Tsapas, Apostolos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Matthews, David R.
    Bekiari, Eleni
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 141 - 141
  • [23] Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
    Bilal, Anika
    Pratley, Richard E.
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (02) : 355 - 375
  • [24] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    C. J. Currie
    C. D. Poole
    E. A. M. Gale
    [J]. Diabetologia, 2009, 52 : 1766 - 1777
  • [25] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
  • [26] Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases
    Prattichizzo, Francesco
    La Sala, Lucia
    Ryden, Lars
    Marx, Nikolaus
    Ferrini, Marc
    Valensi, Paul
    Ceriello, Antonio
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) : 73 - 80
  • [27] Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes
    Bonnet, F.
    Scheen, A. J.
    [J]. DIABETES & METABOLISM, 2017, 43 (04) : 299 - 313
  • [28] Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
    Ferrannini, Ele
    DeFronzo, Ralph A.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (34) : 2288 - U19
  • [29] Initial glucose-lowering therapy and cardiovascular outcomes in type 2 diabetes
    Misnikova, I. V.
    Dreval, A. V.
    Kovaleva, Y. A.
    [J]. DIABETOLOGIA, 2012, 55 : S326 - S326
  • [30] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Inzucchi, Silvio E.
    Peixoto, Aldo J.
    Testani, Jeffrey M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 669 - 670
12345